Advanced in Alveolar Soft Part Sarcoma

Dr. Arta M. Monjazeb

Radiation Oncology
Regents Of The Univ Of Ca
4501 X St, 
Sacramento, CA 
Offers Telehealth
Advanced in Alveolar Soft Part Sarcoma
Regents Of The Univ Of Ca
4501 X St, 
Sacramento, CA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Arta Monjazeb is a Radiation Oncologist in Sacramento, California. Dr. Monjazeb is rated as an Advanced provider by MediFind in the treatment of Alveolar Soft Part Sarcoma. His top areas of expertise are Adult Soft Tissue Sarcoma, Bone Tumor, Anal Cancer, and Angiosarcoma.

His clinical research consists of co-authoring 107 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Radiation Oncology
Licenses
Radiology in CA
Hospital Affiliations
University Of California Davis Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 2 Less Insurance Carriers -

Locations

REGENTS OF THE UNIV OF CA
4501 X St, Sacramento, CA 95817
Other Locations
REGENTS OF THE UNIV OF CA
4860 Y St, Sacramento, CA 95817
REGENTS OF THE UNIV OF CA
2315 Stockton Blvd, Sacramento, CA 95817

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Phase 2 Study of MEDI4736 (Durvalumab) and Tremelimumab Alone or in Combination With High or Low-Dose Radiation in Metastatic Colorectal and NSCLC
A Phase 2 Study of MEDI4736 (Durvalumab) and Tremelimumab Alone or in Combination With High or Low-Dose Radiation in Metastatic Colorectal and NSCLC
Enrollment Status: Active_not_recruiting
Publish Date: July 28, 2025
Intervention Type: Biological, Radiation
Study Drugs: Durvalumab, Tremelimumab
Study Phase: Phase 2
A Phase II Clinical Trial Platform of Sensitization Utilizing Total Neoadjuvant Therapy (TNT) in Rectal Cancer
A Phase II Clinical Trial Platform of Sensitization Utilizing Total Neoadjuvant Therapy (TNT) in Rectal Cancer
Enrollment Status: Completed
Publish Date: April 24, 2024
Intervention Type: Drug, Radiation, Biological
Study Phase: Phase 2
UCDCC#272: A Phase I/II Study of Intralesional IL-2, Hypofractionated Radiotherapy, and Pembrolizumab in Patients Refractory to Standard-of-Care PD-1/PD-L1 Checkpoint Blockade
UCDCC#272: A Phase I/II Study of Intralesional IL-2, Hypofractionated Radiotherapy, and Pembrolizumab in Patients Refractory to Standard-of-Care PD-1/PD-L1 Checkpoint Blockade
Enrollment Status: Unknown
Publish Date: April 10, 2023
Intervention Type: Drug, Radiation
Study Drugs: IL-2, Pembrolizumab
Study Phase: Phase 1/Phase 2
UCDCC#271: A Phase I/II Trial of Epacadostat (Indolamine 2,3 Dioxygenase Inhibitor), Intralesional SD101 (Toll-receptor 9 Agonist), and Radiotherapy in Patients With Advanced Solid Tumors and Lymphoma
UCDCC#271: A Phase I/II Trial of Epacadostat (Indolamine 2,3 Dioxygenase Inhibitor), Intralesional SD101 (Toll-receptor 9 Agonist), and Radiotherapy in Patients With Advanced Solid Tumors and Lymphoma
Enrollment Status: Completed
Publish Date: February 01, 2022
Intervention Type: Radiation, Drug
Study Drugs: Epacadostat, SD-101
Study Phase: Phase 1/Phase 2
UCDCC#269: A Pilot Study of Interlesional IL-2 and Hypofractionated Radiotherapy in Patients With Metastatic Non-small Cell Lung Cancer Who Are Refractory to PD 1 / PD L1 Blockade.
UCDCC#269: A Pilot Study of Interlesional IL-2 and Hypofractionated Radiotherapy in Patients With Metastatic Non-small Cell Lung Cancer Who Are Refractory to PD 1 / PD L1 Blockade.
Enrollment Status: Completed
Publish Date: April 07, 2020
Intervention Type: Radiation, Drug
Study Phase: Early Phase 1
View 4 Less Clinical Trials

107 Total Publications

Updates on radiotherapy-immunotherapy combinations: Proceedings of 8th Annual ImmunoRad Conference.
Updates on radiotherapy-immunotherapy combinations: Proceedings of 8th Annual ImmunoRad Conference.
Journal: Oncoimmunology
Published: May 22, 2025
Similar Doctors
Distinguished in Alveolar Soft Part Sarcoma
Dr. Shyam S. Rao
Radiation Oncology
Distinguished in Alveolar Soft Part Sarcoma
Dr. Shyam S. Rao
Radiation Oncology

Regents Of The Univ Of Ca

2315 Stockton Blvd, 
Sacramento, CA 
 (0.2 miles away)
916-734-2011
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Shyam Rao is a Radiation Oncologist in Sacramento, California. Dr. Rao is rated as a Distinguished provider by MediFind in the treatment of Alveolar Soft Part Sarcoma. His top areas of expertise are Tongue Cancer, Nasopharyngeal Carcinoma, Angiosarcoma of the Scalp, Bone Tumor, and Gastrostomy.

Advanced in Alveolar Soft Part Sarcoma
Dr. Clayton B. Hess
Radiation Oncology
Advanced in Alveolar Soft Part Sarcoma
Dr. Clayton B. Hess
Radiation Oncology

Grass Valley Radiation Oncology

300 Sierra College Dr, Suite 150, 
Grass Valley, CA 
 (51.8 miles away)
530-274-6600
Languages Spoken:
English, Spanish
See accepted insurances
Offers Telehealth

Clayton Hess is a Radiation Oncologist in Grass Valley, California. Dr. Hess is rated as an Advanced provider by MediFind in the treatment of Alveolar Soft Part Sarcoma. His top areas of expertise are Adult Soft Tissue Sarcoma, Anal Cancer, Posterior Fossa Tumor, and Lung Cancer.

Experienced in Alveolar Soft Part Sarcoma
Dr. Darwin D. Yip
Radiation Oncology
Experienced in Alveolar Soft Part Sarcoma
Dr. Darwin D. Yip
Radiation Oncology

Valley Cancer Medical Center Inc

1138 Norman Dr, 
Manteca, CA 
 (54.3 miles away)
209-823-1609
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Darwin Yip is a Radiation Oncologist in Manteca, California. Dr. Yip is rated as an Advanced provider by MediFind in the treatment of Alveolar Soft Part Sarcoma. His top areas of expertise are Chordoma, Ewing Sarcoma, Bone Tumor, and Angiosarcoma of the Scalp.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Monjazeb's expertise for a condition
ConditionClose
View All 12 Advanced Conditions
View All 52 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile